Sunny Singh

Sunny Singh is a highly accomplished pharmaceutical executive with extensive experience in global marketing, strategic planning, and commercial development across various therapeutic areas, particularly oncology and Alpha-1 Antitrypsin Deficiency. Currently serving as VP of Global Marketing and Disease Area Executive at Vertex Pharmaceuticals, Sunny Singh has previously held leadership roles including Executive Director of Strategic Planning and Operations, Senior Director of Patient Adherence and Global Pipeline Marketing, and Chief of Staff for Global Research. Prior professional experience includes key positions at AVEO Oncology, Bayer HealthCare, and Johnson & Johnson. Sunny Singh holds an MBA in Strategy and Corporate Finance from NYU Stern School of Business and a Doctor of Pharmacy from Rutgers University.